Prediction: Pfizer Stock Could Double If Pipeline Delivers
Pfizer stock is navigating a pivot from COVID-era revenues to a broader drug portfolio. Analysts weigh the odds of a ...
Discover how to determine which total market fund has the lowest expense ratio, plus practical steps to compare options effectively.
28,590 articlesPfizer stock is navigating a pivot from COVID-era revenues to a broader drug portfolio. Analysts weigh the odds of a ...
Geopolitical tensions are sparking volatility in the helium market. This report explains how a disruption in helium s...
Lime’s IPO plans put micro-mobility in the spotlight. This article explains why a seasoned investor might prefer an e...
A high-flying biotech spin-off has faced a brutal disconnect between hype and reality. This beaten-down growth stock ...
Joby Aviation posted record Q4 2025 revenue driven by the Blade acquisition, but the stock remains volatile as cash b...
Bazooka’s CIO is deploying broad AI initiatives to boost demand forecasting, marketing speed, and supply chains as th...
Accenture posted solid earnings but offered a cautious outlook, prompting a market selloff. Analysts point to two mai...
As Bitcoin sits in the current price range, analysts lay out a spectrum of 2030 outcomes. This story unpacking scenar...
Meta Platforms has shown business momentum even as its stock traded lower. This guide weighs the case to buy, sell, o...
The strait hormuz back under renewed conflict tests oil bulls and hedges. Markets brace for higher volatility as crud...
A four-name AI momentum basket — NVIDIA, AMD, Palantir and TESLA — drives 2027–2029 price targets as AI demand and EV...
Microsoft’s Satya Nadella signals a data-centric AI strategy, arguing buyers must reveal proprietary know-how to unlo...